Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis.

Rona M Smith Rachel Bronwen JonesUlrich SpecksSimon BondMarianna NodaleReem AljayyousiJacqueline AndrewsAnnette BruchfeldBrian CamilleriSimon CaretteChee Kay CheungVimal DerebailTim DoultonLindsy ForbessShouichi FujimotoShunsuke FurutaOra Gewurz-SingerLorraine HarperToshiko Ito-IharaNader KhalidiRainer KlockeCurry KoeningYoshinori KomagataCarol LangfordPeter LanyonRaashid Ahmed LuqmaniHirofumi MakinoCarole A McAlearPaul MonachLarry W MorelandKim MynardPatrick NachmanChristian PagnouxFiona PearceChen Au PehCharles PuseyDwarakanathan RanganathanRennie L RheeRobert SpieraAntoine G SreihVladimir TesarGiles D WaltersMichael H WeismanCaroline WroePeter A MerkelDavid Jaynenull nullnull null

Published in: Annals of the rheumatic diseases (2020)

This large prospective cohort of patients with relapsing AAV treated with rituximab in conjunction with glucocorticoids demonstrated a high level of efficacy for the reinduction of remission in patients with AAV who have relapsed, with a similar safety profile to previous studies.

Keyphrases